AIPLA Comments on FDA Biosimilars Draft Guidances
May 24, 2012
File Downloads
All documents are in PDF format.
While the Food and Drug Administration’s role in the scientific regulation of biologic drugs is generally outside this primary interest, implementation of the new abbreviated regulatory pathway for biosimilar products authorized under the Biologics Price Competition and Innovation Act of 2009 (BPCIA) contains some aspects that impact intellectual property rights, including patents, trademarks, trade secrets, regulatory exclusivity, and IP litigation.
In view of this impact, AIPLA provides comments on those aspects of the Draft Guidances that more or less directly impact intellectual property rights, and therefore impact our membership. Specifically, AIPLA provides comments on three issues: (1) definition of “protein (except any chemically synthesized polypeptide)”; (2) molecules having a changed amino acid sequence compared with the reference product; and (3) publication of exclusivity expiration dates.
In view of this impact, AIPLA provides comments on those aspects of the Draft Guidances that more or less directly impact intellectual property rights, and therefore impact our membership. Specifically, AIPLA provides comments on three issues: (1) definition of “protein (except any chemically synthesized polypeptide)”; (2) molecules having a changed amino acid sequence compared with the reference product; and (3) publication of exclusivity expiration dates.
Current Status
Upcoming Events
-
Partnering in Patents - Mechanical Arts
November 13, 2024 8:30 AM to 4:45 PM | No CLE
Learn and share ideas about mechanical disciplines at the Technology Centers (TC) 3600 and 3700 and American Intellectual Property Law Association (AIPLA) Customer Partnership Meeting on Wednesday, November 13, from 8:30 a.m. to 4:45 p.m. ET, at the United States Patent and Trademark Office (USPTO) headquarters in Alexandria, Virginia. The meeting will feature perspectives from USPTO examiners, practitioners, and the industry, focusing on better examiner-practitioner interactions for high-quality patents. We'll address topics such as: Artificial intelligence (AI) subject matter eligibility USPTO search tools Drafting patent specifications Approaches to examiner interviews in the mechanical arts -
2025 Leadership Forum
January 29 to 30, 2025
AIPLA Leadership Forum – Elevate Yourself, Inspire the Future. This invitation-only two-day program will address building strong leadership skills for all levels of experience. More details coming soon. -
2025 AIPLA Spring Meeting
May 13 to 15, 2025
Save the Date! The 2025 Spring Meeting is a 2.5 day conference focused on trending topics in IP law. Registration opens February 2025.